SEC Form 4 · accession 0000899243-18-021004
Surface Oncology, Inc. · SURF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Liisa I Nogelo
Officer — General Counsel
Period of report
Aug 1, 2018
Accepted (ET)
Aug 1, 2018 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001718108
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.54 | Aug 1, 2018 | A | 115,000 | A | — | Aug 1, 2028 | Common Stock | 115,000 | 115,000 | D |
Explanation of responses
- F125% of this option shall vest on July 23, 2019 and the remaining 75% shall vest in 36 equal monthly installments thereafter.